首页> 外文OA文献 >A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R Study

【2h】

A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R Study

机译：将血浆药物浓度与2个非核苷逆转录酶抑制剂在艾滋病毒感染患者中的血浆药物浓度和疗效进行比较的随机试验，接受利福平的患者：N2R研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Weerawat Manosuthi; Somnuek Sungkanuparph; Preecha Tantanathip; Aroon Lueangniyomkul; Wiroj Mankatitham; Wisit Prasithsirskul; Sunantha Burapatarawong; Supeda Thongyen; Sirirat Likanonsakul; Unchana Thawornwa; Vilaiwan Prommool; Kiat Ruxrungtham;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study. [J] . Manosuthi W, Sungkanuparph S, Tantanathip P Clinical infectious diseases . 2009,第12期

机译：N2R研究比较了2种基于非核苷类逆转录酶抑制剂的方案在接受利福平治疗的HIV感染患者中的血浆药物浓度和疗效的随机试验：N2R研究。
2. A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor-Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N₂R Study [J] . Weerawat Manosuthi12 Somnuek Sungkanuparph2 Preecha Tantanathip1 Aroon Lueangniyomkul1 Wiroj Mankatitham1 Wisit Prasithsirskul1 Sunantha Burapatarawong1 Supeda Thongyen1 Sirirat Likanonsakul1 Unchana Thawornwa1 Vilaiwan Prommool1 Kiat Ruxrungtham34 and the Nsub2/subR Study Team Clinical Infectious Diseases . 2009,第12期

机译：N _{2 R研究比较HIV感染患者接受利福平的2种非核苷类逆转录酶抑制剂为基础的血浆药物浓度和功效之间的随机对照}
3. Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial. [J] . Miro JM, Manzardo C, Pich J, AIDS Research and Human Retroviruses . 2010,第7期

机译：使用基于非核苷类逆转录酶抑制剂或基于加强型蛋白酶抑制剂的抗逆转录病毒方案，对严重免疫抑制的抗1型抗逆转录病毒初治HIV感染患者进行的免疫重建：三年结果（The Advanz试验）：一项随机对照试验。
4. Dyslipidemia among HIV-infected tuberculosis patients taking once-daily non-nucleoside reverse transcriptase inhibitor based antiretroviral therapy in India. [D] . Chandrasekaran, Padmapriyadarsini. 2010

机译：在印度，每天接受一次基于非核苷类逆转录酶抑制剂的抗逆转录病毒疗法的HIV感染结核病患者的血脂异常。
5. A Phase III Comparative Study of the Efficacy and Tolerability of Three Non-Nucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers: A Randomized Controlled Trial [O] . Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo, -1

机译：三种非核苷类逆转录酶抑制剂-抗逆转录病毒疗法治疗未接受过HIV-1感染的志愿者的疗效和耐受性的III期比较研究：一项随机对照试验
6. Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study. [O] . Patricia Echeverría, Anna Bonjoch, Jordi Puig, 2014

机译：随机研究评估每日一次的基于etravirine的方案作为接受含蛋白酶抑制剂的方案的HIV感染患者的转换策略的功效和安全性。 Etraswitch研究。

A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N2R Study

著录项

相似文献

相关主题

期刊订阅